Blue Edge Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53M | Buy |
18,533
+2,029
| +12% | +$473K | 0.6% | 45 |
|
|
2025
Q4 | $3.42M | Buy |
16,504
+149
| +0.9% | +$29.5K | 0.46% | 54 |
|
|
2025
Q3 | $3.03M | Hold |
16,355
| – | – | 0.43% | 54 |
|
|
2025
Q2 | $2.5M | Sell |
16,355
-21
| -0.1% | -$3.23K | 0.37% | 55 |
|
|
2025
Q1 | $2.72M | Buy |
16,376
+4
| +0% | +$626 | 0.44% | 50 |
|
|
2024
Q4 | $2.37M | Hold |
16,372
| – | – | 0.37% | 54 |
|
|
2024
Q3 | $2.65M | Hold |
16,372
| – | – | 0.41% | 54 |
|
|
2024
Q2 | $2.39M | Buy |
16,372
+24
| +0.1% | +$3.57K | 0.4% | 59 |
|
|
2024
Q1 | $2.59M | Sell |
16,348
-10,840
| -40% | -$1.73M | 0.43% | 58 |
|
|
2023
Q4 | $4.26M | Buy |
27,188
+343
| +1% | +$52.6K | 0.8% | 34 |
|
|
2023
Q3 | $4.18M | Buy |
26,845
+31
| +0.1% | +$5.12K | 0.88% | 35 |
|
|
2023
Q2 | $4.44M | Buy |
26,814
+50
| +0.2% | +$8.07K | 0.89% | 32 |
|
|
2023
Q1 | $4.15M | Buy |
26,764
+377
| +1% | +$60.9K | 0.9% | 35 |
|
|
2022
Q4 | $4.66M | Buy |
26,387
+21
| +0.1% | +$3.63K | 1.06% | 29 |
|
|
2022
Q3 | $4.31M | Buy |
26,366
+146
| +0.6% | +$24.7K | 1.07% | 29 |
|
|
2022
Q2 | $4.65M | Sell |
26,220
-222
| -0.8% | -$39.6K | 1.08% | 29 |
|
|
2022
Q1 | $4.69M | Buy |
26,442
+165
| +0.6% | +$28.1K | 0.94% | 37 |
|
|
2021
Q4 | $4.5M | Hold |
26,277
| – | – | 0.87% | 35 |
|
|
2021
Q3 | $4.24M | Hold |
26,277
| – | – | 0.89% | 35 |
|
|
2021
Q2 | $4.33M | Sell |
26,277
-30
| -0.1% | -$4.97K | 0.9% | 37 |
|
|
2021
Q1 | $4.32M | Buy |
26,307
+202
| +0.8% | +$32.7K | 0.96% | 33 |
|
|
2020
Q4 | $4.11M | Buy |
26,105
+58
| +0.2% | +$8.56K | 0.99% | 32 |
|
|
2020
Q3 | $3.88M | Sell |
26,047
-882
| -3% | -$131K | 1.06% | 29 |
|
|
2020
Q2 | $3.79M | Buy |
26,929
+10,598
| +65% | +$1.54M | 1.14% | 27 |
|
|
2020
Q1 | $2.14M | Buy |
16,331
+5,333
| +48% | +$757K | 0.78% | 36 |
|
|
2019
Q4 | $1.55M | Hold |
10,998
| – | – | 0.49% | 41 |
|
|
2019
Q3 | $1.42M | Hold |
10,998
| – | – | 0.49% | 45 |
|
|
2019
Q2 | $1.53M | Hold |
10,998
| – | – | 0.54% | 45 |
|
|
2019
Q1 | $1.54M | Buy |
10,998
+2
| +0% | +$268 | 0.58% | 41 |
|
|
2018
Q4 | $1.42M | Buy |
10,996
+3
| +0% | +$418 | 0.61% | 42 |
|
|
2018
Q3 | $1.52M | Buy |
10,993
+3
| +0% | +$399 | 0.56% | 47 |
|
|
2018
Q2 | $1.33M | Buy |
10,990
+3
| +0% | +$374 | 0.53% | 47 |
|
|
2018
Q1 | $1.41M | Buy |
10,987
+2
| +0% | +$270 | 0.57% | 47 |
|
|
2017
Q4 | $1.53M | Buy |
10,985
+2,503
| +30% | +$349K | 0.61% | 43 |
|
|
2017
Q3 | $1.1M | Buy |
8,482
+2
| +0% | +$265 | 0.5% | 55 |
|
|
2017
Q2 | $1.12M | Buy |
8,480
+1,269
| +18% | +$162K | 0.53% | 55 |
|
|
2017
Q1 | $898K | Buy |
7,211
+3
| +0% | +$358 | 0.45% | 59 |
|
|
2016
Q4 | $830K | Buy |
7,208
+3
| +0% | +$347 | 0.47% | 60 |
|
|
2016
Q3 | $851K | Buy |
7,205
+2
| +0% | +$243 | 0.46% | 61 |
|
|
2016
Q2 | $874K | Buy |
7,203
+3
| +0% | +$341 | 0.48% | 61 |
|
|
2016
Q1 | $779K | Buy |
7,200
+3,785
| +111% | +$392K | 0.46% | 62 |
|
|
2015
Q4 | $351K | Hold |
3,415
| – | – | 0.23% | 64 |
|
|
2015
Q3 | $319K | Hold |
3,415
| – | – | 0.23% | 63 |
|
|
2015
Q2 | $333K | Sell |
3,415
-288
| -8% | -$28.8K | 0.22% | 64 |
|
|
2015
Q1 | $373K | Hold |
3,703
| – | – | 0.25% | 62 |
|
|
2014
Q4 | $387K | Hold |
3,703
| – | – | 0.27% | 62 |
|
|
2014
Q3 | $395K | Hold |
3,703
| – | – | 0.28% | 62 |
|
|
2014
Q2 | $387K | Sell |
3,703
-67
| -2% | -$6.77K | 0.26% | 62 |
|
|
2014
Q1 | $370K | Buy |
3,770
+155
| +4% | +$14.4K | 0.26% | 60 |
|
|
2013
Q4 | $331K | Buy |
+3,615
| New | +$333K | 0.24% | 62 |
|
Other funds holding JNJ
VCM
VPM
Blue Edge Capital's JNJ Position: Q1 2026 in Review
Blue Edge Capital increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $473K and bringing the position to 18,533 shares worth $4.53M. The position accounts for 0.6% of the portfolio, ranked #45.
Blue Edge Capital first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.69M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Blue Edge Capital held 18,533 shares of Johnson & Johnson worth $4.53M as of Q1 2026.
- Blue Edge Capital bought 2,029 Johnson & Johnson shares in Q1 2026, an estimated $473K.
- Johnson & Johnson made up 0.6% of Blue Edge Capital's portfolio in Q1 2026, its #45 holding.
- Blue Edge Capital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
- Blue Edge Capital's Johnson & Johnson position peaked at $4.69M in Q1 2022.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Blue Edge Capital's 13F filing for Q1 2026, filed 2 Jun 2026.